PNA-CONJUGATE OR PNACONJUGATE MIXTURE FOR TREATING DISEASES RELATED TO THE HUMAN PAPILLOMAVIRUS

Details for Australian Patent Application No. 2002350387 (hide)

Owner DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS

Inventors BRAUN, Klaus; WALDECK, Waldemar; PIPKORN, Rudiger; BRAUN, Isabell; DEBUS, Jurgen

Pub. Number AU-A-2002350387

PCT Number PCT/DE02/04153

PCT Pub. Number WO2003/040365

Priority 101 54 831.1 08.11.01 DE

Filing date 8 November 2002

Wipo publication date 19 May 2003

International Classifications

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

A61K 047/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 031/7125 - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 035/00 Antineoplastic agents

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 101 54 831.1 08.11.01 DE

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002350387

22 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002350388-Shoe

2002350386-ORALLY ADMINISTERED PHARMACEUTICAL PREPARATION COMPRISING LIPOSOMICALLY ENCAPSULATED PACLITAXEL